It was big, bold, complicated - and a blowout deal. Facing regulatory challenges, market volatility, rising rates, and doubtful investors, drugstore chain CVS Health's US$40bn nine-part jumbo US dollar bond issue to back the acquisition of health insurer Aetna set a record, a precedent for pricing, and was the US high-grade market's third biggest issue ever.
展开▼
